Abstract
Eight infants (6 female, 2 male) with salt-losing congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency were studied to determine the sodium deficit at diagnosis and the level of salt supplement required in addition to subsequent hormone replacement. The median sodium deficit at diagnosis was 34 mmol (range 16–78) or 10.5 mmol/kg (range 4–24). A mean sodium supplement of 2.2 mmol/kg per day (range 0.5–4.9), double the amount provided with feeds, was required to maintain plasma sodium concentration and plasma renin activity (PRA) in the normal range for age. We present an equation based on sodium output (urine), sodium input (feeding plus supplement) and plasma sodium concentration to calculate the sodium supplement needed to maintain sodium balance on hormone replacement in this condition and some practical management suggestions. The necessity for salt supplements is often underestimated and the salt-losing tendency exacerbated by infection remains an unnecessary reason for hospitalization during the first months of life. In patients with salt-losing CAH life-long mineralocorticoid treatment is necessary but additional salt supplements are needed to maintain plasma sodium concentration and PRA in the normal range during infancy.
Similar content being viewed by others
Abbreviations
- CAH:
-
congenital adrenal hyperplasia
- P-450c21:
-
microsomal cytochrome P-450 specific for 21-hydroxylase
- PRA:
-
plasma renin activity
- TBW:
-
total body water
References
Appan S, Hindmarsh PC, Brook CGD (1989) Monitoring treatment in congenital adrenal hyperplasia. Arch Dis Child 64:1235–1239
Chaptal J, Jean R, Guillaumot R, Morel G (1963) Etude statistique de l'elimination urnaire des electrolytes chez l'enfant normal a differents ages. Arch Fr Pediatr 20:905–931
Darrow DC, Yannet H (1935) The changes in the distribution of body water accompanying increase and decrease in extracellular electrolyte. J Clin Invest 14:266–275
Dillon MJ, Gillin MEA, Ryness JM, De Swiet M (1976) Plasma renin activity and aldosterone concentration in the human newborn. Arch Dis Chid 51:537–540
Dyas J, Read GF, Maulik TJ, Hughes IA, Riad-Fahmy D (1984) A rapid assay for 17-OH progesterone in plasma, saliva and amniotic fluid using a magnetisable solid-phase antiserum. Ann Clin Biochem 21:414–417
Feeley RM, Criner PE, Murphy EW, Toepfer EW (1972) Major mineral elements in dairy products. J Am Diet Assoc 61:505–510
Grant DB, Dillon MJ, Atherden SM, Levinski RJ (1977) Congenital adrenal hyperplasia: renin and steroid values during treatment. Eur J Pediatr 126:89–96
Gueux B, Fiet J, Galons H, Bonete R, Villette JM, Vexiau P, Pham-Huu-Trung MT, Raux-Eurin MC, Gourmelen M, Brerault JL, Julien R, Dreux C (1987) The measurement of 11 beta-hydroxy-4-pregnene-3,20 dione (21-deoxycorticosterone) by radioimmunoassay in human plasma. J Steroid Biochem 26: 145–159
Harmon W (1973) Fluid and electrolytes. In: Graef JW, Cone ThE (eds) Manual of pediatric therapeutics. Little, Brown and Company, Boston, pp 189–207
Horner JM, Hintz RL, Leutscher JA (1979) The role of renin and angiotensin in salt-losing, 21-hydroxylase deficient adrenal hyperplasia. J Clin Endocrinol Metab 48:776–783
Hughes IA (1988) Management of congenital adrenal hyperplasia. Arch Dis Child 63:1399–1404
Jacobs DR (1969) Natriuretic activity of 16-alpha-hydroxyprogesterone in man. Acta Endocrinol (Copenh) 61:275–281
Kirkland RT, Kirkland JL (1972) Systolic blood pressure measurement in newborn infants with transcutaneous. Dopplermethod. J Pediatr 80:52–56
Kominani S, Ochi H, Kobayashi Y, Takemori S (1980) Studies on the steroid hydroxylation system in adrenal cortex microsomes: purification and characterization of cytochrome P-450 specific for steroid C-21 hydroxylation. J Biol Chem 255:3386–3394
Laiken ND, Fanestil DD (1985) Body fluid and renal function. In: West JB (ed) Physiological basis of medical practice. Williams & Wilkins, Baltimore, pp 438–450
Macy IG (1949) Composition of human colostrum and milk. Am J Dis Child 78:589–603
Matteson KJ, Phillips JA, Miller WL, Chung BC, Orlando PJ, Frisch H, Ferrandez A, Burr IA (1987) P 450XXI (steroid 21 hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia. Proc Natl Acad Sci USA 84: 5858–5862
Menhard J, Catt KJ (1972) Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 90:422–430
Miller WL, Levine LS (1987) Molecular and clinical advances in congenital adrenal hyperplasia. J Pediatr 111:1–17
Morel Y, David M, Forest MG, Betuel H, Hauptman G, Andre J, Bertrand J, Miller WL (1989) Gene conversions and rearrangements cause discordance between inheritance of forms of 21 hydroxylase deficiency and HLA types. J Clin Endocrinol Metab 68:592–599
Morgan DB (1984) Body water, sodium, potassium and hydrogen ions: some basic facts and concepts. Clin Endocrinol Metab 233–247
Prader A (1954) Der Genitalbefund beim Pseudohermaphroditismus femininus des kongenitalen adrenogenitalen Syndroms. Morphologie, Häufigkeit, Entwicklung und Vererbung der verschiedenen Genitalformen. Helv Paediatr Acta 9:231–243
Rosler A, Levine LS, Schneider B, Novogroder M, New MI (1977) The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 45:500–512
Widdowson EM, McCance RA, Harrison GE, Sutton A (1962) Metabolism of calcium, strontium and other minerals in the perinatal period. Lancet II:373–374
Winter JSD (1980) Current approaches to the treatment of congenital adrenal hyperplasia. J Pediatr 97:81–82
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mullis, P.E., Hindmarsh, P.C. & Brook, C.G.D. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. Eur J Pediatr 150, 22–25 (1990). https://doi.org/10.1007/BF01959473
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01959473